Pediatric Vaccine Market Size, Share, And Growth Report 2032

Pediatric Vaccine Market

Pediatric Vaccine Market By Vaccine Type (Monovalent and Multivalent), By Administration Method (Oral, Intramuscular, and Subcutaneous), By Disease Type (Meningococcal Disease, Hepatitis, Influenza, Polio, Pneumococcal Disease, DTP, MMR, Dengue, Rotavirus, HPV, Varicella, Herpes Zoster, and Others), By Technology (Recombinant Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, and Live Attenuated Vaccines), and By End-User (Hospitals, Healthcare Providers, and Others), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032

Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-4574 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 19.80 Billion USD 36.10 Billion 6.9% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Pediatric Vaccine Market Revenue, 2016-2025 (USD Billion)
    • 2.2. Global Pediatric Vaccine Market: Snapshot
  •  
  • Chapter 3. Pediatric Vaccine- Market: Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Pediatric Vaccine Market Drivers: Impact Analysis
      • 3.2.2. The growing prevalence of infectious diseases
      • 3.2.3. The increasing disposable income
      • 3.2.4. Multiple immunization programs by governments
      • 3.2.5. Rising awareness about the importance of preventive care
    • 3.3. Market restraints
      • 3.3.1. High vaccine cost
    • 3.4. Opportunities
      • 3.4.1. Emerging Markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Vaccine Type
      • 3.6.2. Market attractiveness analysis, by Disease Type
      • 3.6.3. Market attractiveness analysis, by Administration Method
      • 3.6.4. Market attractiveness analysis, by Technology
      • 3.6.5. Market attractiveness analysis, by End-User
      • 3.6.6. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Pediatric Vaccine Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Pediatric Vaccine Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Applications Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Pediatric Vaccine Market - Vaccine Type Analysis
    • 5.1. Global Pediatric Vaccine Market: Vaccine Type overview
      • 5.1.1. Global Pediatric Vaccine Market share, by Vaccine Type, 2018 and 2025
    • 5.2. Monovalent vaccines
      • 5.2.1. Global Pediatric Vaccine Market for monovalent vaccines, 2016-2025 (USD Billion)
    • 5.3. Multivalent vaccines
      • 5.3.1. Global Pediatric Vaccine Market for multivalent vaccines, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Pediatric Vaccine Market - Disease Type Analysis
    • 6.1. Global Pediatric Vaccine Market: Disease Type overview
      • 6.1.1. Global Pediatric Vaccine Market share, by Disease Type, 2018 and 2025
    • 6.2. Dengue
      • 6.2.1. Global Pediatric Vaccine Market for Dengue, 2016-2025 (USD Billion)
    • 6.3. Pneumococcal Disease
      • 6.3.1. Global Pediatric Vaccine Market for Pneumococcal Disease, 2016-2025 (USD Billion)
    • 6.4. Hepatitis
      • 6.4.1. Global Pediatric Vaccine Market for Hepatitis, 2016-2025 (USD Billion)
    • 6.5. MMR
      • 6.5.1. Global Pediatric Vaccine Market for MMR, 2016-2025 (USD Billion)
    • 6.6. Varicella
      • 6.6.1. Global Pediatric Vaccine Market for Varicella, 2016-2025 (USD Billion)
    • 6.7. Polio
      • 6.7.1. Global Pediatric Vaccine Market for Polio, 2016-2025 (USD Billion)
    • 6.8. Influenza
      • 6.8.1. Global Pediatric Vaccine Market for Influenza, 2016-2025 (USD Billion)
    • 6.9. DTP
      • 6.9.1. Global Pediatric Vaccine Market for DTP, 2016-2025 (USD Billion)
    • 6.10. Herpes Zoster
      • 6.10.1. Global Pediatric Vaccine Market for Herpes Zoster, 2016-2025 (USD Billion)
    • 6.11. Rotavirus
      • 6.11.1. Global Pediatric Vaccine Market for Rotavirus, 2016-2025 (USD Billion)
    • 6.12. Human Papilloma Virus (HPV)
      • 6.12.1. Global Pediatric Vaccine Market for Human Papilloma Virus (HPV), 2016-2025 (USD Billion)
    • 6.13. Meningococcal Disease
      • 6.13.1. Global Pediatric Vaccine Market for Meningococcal Disease, 2016-2025 (USD Billion)
    • 6.14. Others
      • 6.14.1. Global Pediatric Vaccine Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Pediatric Vaccine Market - Technology Analysis
    • 7.1. Global Pediatric Vaccine Market: Technology segment overview
      • 7.1.1. Global Pediatric Vaccine Market share, by Technology, 2018 and 2025
    • 7.2. Recombinant Vaccines
      • 7.2.1. Global Pediatric Vaccine Market for Recombinant Vaccines, 2016-2025 (USD Billion)
    • 7.3. Inactivated Vaccines
      • 7.3.1. Global Pediatric Vaccine Market for Inactivated Vaccines, 2016-2025 (USD Billion)
    • 7.4. Conjugate Vaccines
      • 7.4.1. Global Pediatric Vaccine Market for Conjugate Vaccines, 2016-2025 (USD Billion)
    • 7.5. Toxoid Vaccines
      • 7.5.1. Global Pediatric Vaccine Market for Toxoid Vaccines, 2016-2025 (USD Billion)
    • 7.6. Live Attenuated Vaccines
      • 7.6.1. Global Pediatric Vaccine Market for Live Attenuated Vaccines, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Pediatric Vaccine Market - Administration Method Analysis
    • 8.1. Global Pediatric Vaccine Market: Administration Method overview
      • 8.1.1. Global Pediatric Vaccine Market share, by Administration Method, 2018 and 2025
    • 8.2. Oral
      • 8.2.1. Global Pediatric Vaccine Market for oral, 2016-2025 (USD Billion)
    • 8.3. Intramuscular
      • 8.3.1. Global Pediatric Vaccine Market for intramuscular, 2016-2025 (USD Billion)
    • 8.4. Subcutaneous
      • 8.4.1. Global Pediatric Vaccine Market for subcutaneous, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global Pediatric Vaccine Market - End-User Analysis
    • 9.1. Global Pediatric Vaccine Market: End-User overview
      • 9.1.1. Global Pediatric Vaccine Market share, by End-User, 2018 and 2025
    • 9.2. Hospitals
      • 9.2.1. Global Pediatric Vaccine Market for Hospitals, 2016-2025 (USD Billion)
    • 9.3. Healthcare Providers
      • 9.3.1. Global Pediatric Vaccine Market for Healthcare Providers, 2016-2025 (USD Billion)
    • 9.4. Others
      • 9.4.1. Global Pediatric Vaccine Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Global Pediatric Vaccine Market - Regional Analysis
    • 10.1. Global Pediatric Vaccine Market: Regional overview
      • 10.1.1. Global Pediatric Vaccine Market share, by region, 2018 and 2025
    • 10.2. North America
      • 10.2.1. North America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.2.2. North America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.2.3. North America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.2.4. North America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.2.5. North America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.2.6. The U.S.
        • 10.2.6.1. The U.S. Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.2.6.2. The U.S. Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.2.6.3. The U.S. Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.2.6.4. The U.S. Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.2.6.5. The U.S. Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.2.7. Rest of North America
        • 10.2.7.1. Rest of North America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.2.7.2. Rest of North America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.2.7.3. Rest of North America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.2.7.4. Rest of North America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.2.7.5. Rest of North America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.3. Europe
      • 10.3.1. Europe Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.3.2. Europe Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.3.3. Europe Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.3.4. Europe Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.3.5. Europe Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.6. Germany
        • 10.3.6.1. Germany Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.6.2. Germany Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.6.3. Germany Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.6.4. Germany Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.6.5. Germany Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.7. The U.K.
        • 10.3.7.1. U.K. Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.7.2. U.K. Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.7.3. U.K. Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.7.4. U.K. Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.7.5. U.K. Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.8. France
        • 10.3.8.1. France Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.8.2. France Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.8.3. France Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.8.4. France Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.8.5. France Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.9. Rest of Europe
        • 10.3.9.1. Rest of Europe Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.9.2. Rest of Europe Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.9.3. Rest of Europe Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.9.4. Rest of Europe Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.9.5. Rest of Europe Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.4.2. Asia Pacific Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.4.3. Asia Pacific Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.4.4. Asia Pacific Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.4.5. Asia Pacific Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.6. China
        • 10.4.6.1. China Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.6.2. China Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.6.3. China Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.6.4. China Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.6.5. China Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.7. Japan
        • 10.4.7.1. Japan Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.7.2. Japan Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.7.3. Japan Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.7.4. Japan Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.7.5. Japan Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.8. India
        • 10.4.8.1. India Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.8.2. India Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.8.3. India Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.8.4. India Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.8.5. India Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.9. Rest of Asia Pacific
        • 10.4.9.1. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.9.2. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.9.3. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.9.4. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.9.5. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.5. Latin America
      • 10.5.1. Latin America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.5.2. Latin America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.5.3. Latin America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.5.4. Latin America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.5.5. Latin America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.5.6. Brazil
        • 10.5.6.1. Brazil Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.5.6.2. Brazil Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.5.6.3. Brazil Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.5.6.4. Brazil Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.5.6.5. Brazil Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.5.7. Rest of Latin America
        • 10.5.7.1.
        • Rest of Latin America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.5.7.2. Rest of Latin America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.5.7.3. Rest of Latin America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.5.7.4. Rest of Latin America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.5.7.5. R
        • est of Latin America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.6. The Middle East and Africa
      • 10.6.1. The Middle East and Africa Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.6.2. The Middle East and Africa Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.6.3. The Middle East and Africa Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.6.4. The Middle East and Africa Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.6.5. The Middle East and Africa Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 11. Company Profile
    • 11.1. Mitsubishi Tanabe Pharma
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Therapy portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. Astellas Pharma
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Therapy portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Johnson & Johnson
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Therapy portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. Pfizer
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Therapy portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. CSL Limited
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Therapy portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. GlaxoSmithKline
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Therapy portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
    • 11.7. Serum Institute of India
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Therapy portfolio
      • 11.7.4. Business strategy
      • 11.7.5. Recent developments
    • 11.8. Panacea Biotec
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Therapy portfolio
      • 11.8.4. Business strategy
      • 11.8.5. Recent developments
    • 11.9. Daiichi Sankyo
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Therapy portfolio
      • 11.9.4. Business strategy
      • 11.9.5. Recent developments
    • 11.10. Merck
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Therapy portfolio
      • 11.10.4. Business strategy
      • 11.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research application
2. Market research methodology
3. Global Pediatric Vaccine Market, 2016–2025 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Pediatric Vaccine Market attractiveness analysis, by Vaccine Type
6. Pediatric Vaccine Market attractiveness analysis, by Disease Type
7. Pediatric Vaccine Market attractiveness analysis, by Technology
8. Pediatric Vaccine Market attractiveness analysis, by Administration Method
9. Pediatric Vaccine Market attractiveness analysis, by End-User
10. Pediatric Vaccine Market attractiveness analysis, by Region
11. Company market share analysis, 2018
12. Global Pediatric Vaccine Market share by Vaccine Type, 2018 and 2025
13. Global Pediatric Vaccine Market for monovalent vaccines, 2016–2025 (USD Billion)
14. Global Pediatric Vaccine Market for multivalent vaccines, 2016–2025 (USD Billion)
15. Global Pediatric Vaccine Market share by Disease Type, 2018 and 2025
16. Global Pediatric Vaccine Market for Dengue, 2016–2025 (USD Billion)
17.  Global Pediatric Vaccine Market for Pneumococcal Disease, 2016–2025 (USD Billion)
18. Global Pediatric Vaccine Market for Hepatitis, 2016–2025 (USD Billion)
19. Global Pediatric Vaccine Market for MMR, 2016–2025 (USD Billion)
20. Global Pediatric Vaccine Market for Varicella, 2016–2025 (USD Billion)
21. Global Pediatric Vaccine Market for Polio, 2016–2025 (USD Billion)
22. Global Pediatric Vaccine Market for Influenza, 2016–2025 (USD Billion)
23. Global Pediatric Vaccine Market for Herpes Zoster, 2016–2025 (USD Billion)
24. Global Pediatric Vaccine Market for Rotavirus, 2016–2025 (USD Billion)
25. Global Pediatric Vaccine Market for DTP, 2016–2025 (USD Billion)
26. Global Pediatric Vaccine Market for Human Papilloma Virus (HPV), 2016–2025 (USD Billion)
27. Global Pediatric Vaccine Market for Meningococcal Disease, 2016–2025 (USD Billion)
28. Global Pediatric Vaccine Market for others, 2016–2025 (USD Billion)
29. Global Pediatric Vaccine Market share by Technology, 2018 and 2025
30. Global Pediatric Vaccine Market for Recombinant Vaccines, 2016–2025 (USD Billion)
31. Global Pediatric Vaccine Market for Inactivated Vaccines, 2016–2025 (USD Billion)
32. Global Pediatric Vaccine Market for Conjugate Vaccines, 2016–2025 (USD Billion)
33. Global Pediatric Vaccine Market for Live Attenuated Vaccines, 2016–2025 (USD Billion)
34. Global Pediatric Vaccine Market for Toxoid Vaccines, 2016–2025 (USD Billion)
35. Global Pediatric Vaccine Market share by Administration Method, 2018 and 2025
36. Global Pediatric Vaccine Market for Oral, 2016–2025 (USD Billion)
37. Global Pediatric Vaccine Market for Intramuscular, 2016–2025 (USD Billion)
38. Global Pediatric Vaccine Market for Subcutaneous, 2016–2025 (USD Billion)
39. Global Pediatric Vaccine Market share by End-User, 2018 and 2025
40.  Global Pediatric Vaccine Market for Hospitals, 2016–2025 (USD Billion)
41. Global Pediatric Vaccine Market for Healthcare Providers, 2016–2025 (USD Billion)
42. Global Pediatric Vaccine Market for others, 2016–2025 (USD Billion)
43. Global Pediatric Vaccine Market share by Region, 2018 and 2025
44. North America Pediatric Vaccine Market Revenue, 2016–2025 (USD Billion)
45. Europe Pediatric Vaccine Market Revenue, 2016–2025 (USD Billion)
46. Asia Pacific Pediatric Vaccine Market Revenue, 2016–2025 (USD Billion)
47. Latin America Pediatric Vaccine Market Revenue, 2016–2025 (USD Billion)
48. The Middle East and Africa Pediatric Vaccine Market Revenue, 2016–2025 (USD Billion)


Table Of Tables

List of Tables

1. Pediatric Vaccine Market: Snapshot
2. Drivers of the Global Pediatric Vaccine Market: Impact analysis 
3. Restraints of the Global Pediatric Vaccine Market: Impact analysis  
4. North America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
5. North America Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
6. North America Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
7. North America Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
8. North America Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
9. The U.S. Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
10. The U.S. Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
11. The U.S. Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
12. The U.S. Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
13. The U.S. Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
14. Rest of North America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
15. Rest of North America Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
16. Rest of North America Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
17. Rest of North America Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
18. Rest of North America Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
19. Europe Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
20. Europe Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
21. Europe Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
22. Europe Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
23. Europe Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
24. Germany Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
25. Germany Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
26. Germany Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
27. Germany Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
28. Germany Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
29. U.K. Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
30. U.K. Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
31. U.K. Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
32. U.K. Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
33. U.K. Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
34. France Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
35. France Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
36. France Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
37. France Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
38. France Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
39. Rest of Europe Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
40. Rest of Europe Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
41. Rest of Europe Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
42. Rest of Europe Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
43. Rest of Europe Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
44. Asia Pacific Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
45. Asia Pacific Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
46. Asia Pacific Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
47. Asia Pacific Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
48. Asia Pacific Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
49. China Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
50. China Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
51. China Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
52. China Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
53. China Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
54. Japan Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
55. Japan Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
56. Japan Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
57. Japan Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
58. Japan Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
59. India Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
60. India Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
61. India Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
62. India Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
63. India Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
64. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
65. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
66. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
67. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
68. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
69. Latin America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
70. Latin America Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
71. Latin America Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
72. Latin America Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
73. Latin America Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
74. Brazil Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
75. Brazil Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
76. Brazil Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
77. Brazil Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
78. Brazil Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
79. Rest of Latin America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
80. Rest of Latin America Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
81. Rest of Latin America Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
82. Rest of Latin America Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
83. Rest of Latin America Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)
84. The Middle East and Africa Pediatric Vaccine Market Revenue, by Vaccine Type, 2016–2025 (USD Billion)
85. The Middle East and Africa Pediatric Vaccine Market Revenue, by Disease Type, 2016–2025 (USD Billion)
86. The Middle East and Africa Pediatric Vaccine Market Revenue, by Technology, 2016–2025 (USD Billion)
87. The Middle East and Africa Pediatric Vaccine Market Revenue, by Administration Method, 2016–2025 (USD Billion)
88. The Middle East and Africa Pediatric Vaccine Market Revenue, by End-User, 2016–2025 (USD Billion)

Methodology

FrequentlyAsked Questions

Pediatric vaccines protect children from complications and serious illnesses, which could lead to paralysis, brain damage, amputations, and even death.

According to study, the Pediatric Vaccine Market size was worth around USD 19.80 billion in 2023 and is predicted to grow to around USD 36.10 billion by 2032.

The CAGR value of Pediatric Vaccine Market is expected to be around 6.9% during 2024-2032.
 

North America has been leading the Pediatric Vaccine Market and is anticipated to continue on the dominant position in the years to come.

The Pediatric Vaccine Market is led by players like Mitsubishi Tanabe Pharma, Astellas Pharma, Johnson & Johnson, Pfizer, CSL Limited, GlaxoSmithKline, Serum Institute of India, Panacea Biotec, Daiichi Sankyo, and Merck.

Choose License Type

  • zion payment modes

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed